1. Sun, Lan, Lin, Peirong, Chen, Ying, Zhao, Liyun, Du, Guanhua. 2020. miR-182-3p/Myadm contribute to pulmonary artery hypertension vascular remodeling via a KLF4/p21-dependent mechanism. In Theranostics, 10, 5581-5599. doi:10.7150/thno.44687. https://pubmed.ncbi.nlm.nih.gov/32373233/
2. Tanyaratsrisakul, Sasipa, Dy, Alane Blythe C, Polverino, Francesca, Numata, Mari, Ledford, Julie G. 2023. Myeloid-associated differentiation marker is associated with type 2 asthma and is upregulated by human rhinovirus infection. In Frontiers in immunology, 14, 1237683. doi:10.3389/fimmu.2023.1237683. https://pubmed.ncbi.nlm.nih.gov/37638015/
3. Yang, Qiuxing, Cai, Bo, Zhu, Shudong, Tai, Guomei, Shen, Aiguo. 2024. Identification and Validation of MYADM as a Novel Prognostic Marker Related to EMT in ESCC. In Journal of Cancer, 15, 5351-5366. doi:10.7150/jca.88767. https://pubmed.ncbi.nlm.nih.gov/39247591/
4. Aranda, Juan F, Reglero-Real, Natalia, Marcos-Ramiro, Beatriz, Alonso, Miguel A, Millán, Jaime. 2012. MYADM controls endothelial barrier function through ERM-dependent regulation of ICAM-1 expression. In Molecular biology of the cell, 24, 483-94. doi:10.1091/mbc.E11-11-0914. https://pubmed.ncbi.nlm.nih.gov/23264465/
智鼠故事 
